| Literature DB >> 1328465 |
C P Larsen1, S C Ritchie, T C Pearson, P S Linsley, R P Lowry.
Abstract
Whereas dendritic cells (DC) are known to be potent activators of T cells both in vitro and in vivo, the critical costimulatory molecules expressed on DC are not well characterized. Using immunocytochemical and molecular techniques we find that splenic DC express B7/BB1, the counter-receptor for CD28. Moreover, expression of B7/BB1 is upregulated on epidermal Langerhans cells (LC) during their functional maturation into potent T cell stimulators. In blocking experiments, we find that participation of B7/BB1 is required for optimal proliferation of unprimed, allogeneic T cells in DC-driven, primary mixed leukocyte reactions. These data demonstrate that the regulated expression of B7/BB1 on DC may be important in the initiation of a primary T cell response.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1328465 PMCID: PMC2119403 DOI: 10.1084/jem.176.4.1215
Source DB: PubMed Journal: J Exp Med ISSN: 0022-1007 Impact factor: 14.307